関連する実験動画
Updated: Feb 23, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
体重が高い成人のための社会正義:体系的なレビュー
Imogen Sophia Weidinger1, Leonie Josefa Renelt2, Solveig Lena Hansen2
1Institute of Public Health and Nursing Research (IPP), University of Bremen, Universitätsallee 1B, 28359, Bremen, Germany. iweidinger@uni-bremen.de.
International journal for equity in health
|February 21, 2026
まとめ
この体系的レビューは,肥満をケーススタディとして用いて,公衆衛生における社会正義を探索しています. 倫理的理論が,健康上の不平等に対処し,高体重の成人のための政策を導くことができるかを強調しています.
科学分野:
- 公共衛生の倫理 公共衛生の倫理
- 社会的正義の理論について
- 肥満に関する研究
背景:
- 健康上の不平等は,社会的・経済的地位や教育など,個人のコントロールを超えた社会的・構造的要因に起因する.
- これらの健康格差に対処するには,公衆衛生における社会正義のための明確な倫理的枠組みが必要です.
- 肥満は,社会正義の原則の概念化と適用を検証するための重要な例です.
研究 の 目的:
- 公共衛生の対応において,社会正義がどのように概念化され,運用されるかを,体系的に検討する.
- 肥満を取り巻く倫理的議論を分析し,健康格差のモデルとして利用する.
- 健康における社会正義を推進するための実用的なステップを特定する.
主な方法:
- PRISMAのガイドラインに従って,PubMed,Web of Science,BeLit.を検索して,体系的なレビューを行いました.
- 2人の著者による独立したスクリーニング,データ抽出,分析.
- ルーヴェン (QUAGOL) の定性分析ガイドフレームワークを使用した定性分析,ATLAS.tiソフトウェアでサポートされています.
主要な成果:
- 肥満に関する倫理的議論は,世界の不平等にもかかわらず,主にグローバル・ノースに焦点を当てています.
- 主なテーマは,責任,自主性,病気の概念,汚名,医療や食料へのアクセスなどです.
- 社会正義の理論は,不正義を特定し,政策を策定するために利用されていますが,コンセンサスは未だに浮上しています.
結論:
- 倫理的理論は,高体重の成人 (AHBW) のための社会正義を促進するための枠組みを提供します.
- このレビューは,学際的な研究と翻訳努力のための実行可能な戦略を特定しています.
- 社会的な決定因子に根ざした健康格差に対処するための基盤を提供します.
関連する概念動画
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients
303
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
303
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
312
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
312
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
226
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
226
Binge Eating Disorders
549
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
549
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K

